Ahead of CPhI Discover, the CPhI executive post-pandemic pharma survey1 predicts that pandemic supply chain issues have further cemented a push for repatriated manufacturing globally. The findings suggest that over the next five years, governments and companies will gradually look to reduce complexity and increase regional self-reliance.   Highlighting this issue’s current prominence, the implications of this shift are to be fully explored by a panel of experts during a live session on Thursday ...